A Study Investigating Coagadex in the Treatment AFXD Associated With AL Amyloidosis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study Investigating Coagadex in the Treatment AFXD Associated With AL Amyloidosis — Stella

Recruiting

Back to Acquired Factor X Deficiency trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(3 sites)

United States

Mayo Clinic Arizona, Phoenix, Arizona

Mayo Clinic Rochester, Rochester, Minnesota

United Kingdom

Cancer Clinical Trials Unit, London, London

Key details

Phase

Large-scale testing

Sponsor

Kedrion S.p.A.

Collaborators

Worldwide Clinical Trials

Enrollment target

~15 participants

Started

February 2026

Primary completion

June 2027

Age range

18 Years – 70 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov